From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY OF THE CELL
Volume 27, Issue 3, Pages 424-433
Publisher
American Society for Cell Biology (ASCB)
Online
2016-01-29
DOI
10.1091/mbc.e14-04-0935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved Clinical and Radiographic Outcomes After Treatment With Ivacaftor in a Young Adult With Cystic Fibrosis With the P67L CFTR Mutation
- (2015) Shatha Yousef et al. CHEST
- Origins of Cystic Fibrosis Lung Disease
- (2015) David A. Stoltz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial
- (2015) Richard B Moss et al. Lancet Respiratory Medicine
- Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
- (2015) Nikhil T. Awatade et al. EBioMedicine
- Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation
- (2015) Daniele Rapino et al. PLoS One
- ΔF508 CFTR Surface Stability Is Regulated by DAB2 and CHIP-Mediated Ubiquitination in Post-Endocytic Compartments
- (2015) Lianwu Fu et al. PLoS One
- CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR
- (2014) Yiting Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population
- (2014) D. C. Taylor-Robinson et al. EUROPEAN RESPIRATORY JOURNAL
- Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
- (2014) Laura Lentini et al. MOLECULAR PHARMACEUTICS
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis
- (2014) Benjamin T. Kopp et al. PEDIATRIC PULMONOLOGY
- A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor
- (2014) Jessica E. Char et al. PLoS One
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Eitan Kerem et al. Lancet Respiratory Medicine
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
- (2013) Xiaojiao Xue et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Corrector VX-809 stabilizes the first transmembrane domain of CFTR
- (2013) Tip W. Loo et al. BIOCHEMICAL PHARMACOLOGY
- Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
- (2013) Carlos M. Farinha et al. CHEMISTRY & BIOLOGY
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
- (2013) Fredrick Van Goor et al. Journal of Cystic Fibrosis
- VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
- (2013) Hong Yu Ren et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Characterization of pulmonary function impairments in patients with mucopolysaccharidoses-changes with age and treatment
- (2013) Shuan-Pei Lin et al. PEDIATRIC PULMONOLOGY
- Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator
- (2012) Alessandro Luciani et al. Autophagy
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
- (2012) Juan L. Mendoza et al. CELL
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
- (2012) Wael M. Rabeh et al. CELL
- Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein
- (2012) Lihua He et al. FASEB JOURNAL
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- (2012) Haihui Yu et al. Journal of Cystic Fibrosis
- Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
- (2012) Alejandro A. Pezzulo et al. NATURE
- Increased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators
- (2011) Ray A. Caldwell et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
- (2011) M. Wilschanski et al. EUROPEAN RESPIRATORY JOURNAL
- Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching
- (2011) Nico Derichs et al. FASEB JOURNAL
- Curcumin and genistein additively potentiate G551D-CFTR
- (2011) Ying-Chun Yu et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- Influence of cell background on pharmacological rescue of mutant CFTR
- (2010) Nicoletta Pedemonte et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
- (2010) Isabelle Sermet-Gaudelus et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Stabilizing Influence: CAL PDZ Inhibition Extends the Half-Life of ΔF508-CFTR
- (2010) Patrick R. Cushing et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Modifier genes in Mendelian disorders: the example of cystic fibrosis
- (2010) Garry R. Cutting Annals of the New York Academy of Sciences
- Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia
- (2010) Jeng-Haur Chen et al. CELL
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
- (2010) T. Okiyoneda et al. SCIENCE
- Cooperative Assembly and Misfolding of CFTR Domains In Vivo
- (2009) Kai Du et al. MOLECULAR BIOLOGY OF THE CELL
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
- (2009) Darren M Hutt et al. Nature Chemical Biology
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Update on gene modifiers in cystic fibrosis
- (2008) Joseph M Collaco et al. CURRENT OPINION IN PULMONARY MEDICINE
- Improvement in clinical markers in CF patients using a reduced glutathione regimen: An uncontrolled, observational study
- (2008) Alfredo Visca et al. Journal of Cystic Fibrosis
- The prevalence of cystic fibrosis in the European Union
- (2008) Philip M. Farrell Journal of Cystic Fibrosis
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
- (2008) M. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now